{"id":"556990-6273","orgnr":"556990-6273","name":"ImmCon AB","name_registered_on":"2014-11-17","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2014-11-17","business_description":"Konsultverksamhet inom området immunologi, immunterapi, cellterapi, vaccinteknologi och genterapi.","industries":[{"code":"72101","name":"Bioteknisk forskning och utveckling"}],"postal_address":{"city":"STOCKHOLM","country":"SE","municipality":{"code":"0180","name":"Stockholm"},"county":{"code":"01","name":"Stockholms län"}},"registered_office":{"municipality":{"code":"0180","name":"Stockholm"},"county":{"code":"01","name":"Stockholms län"}},"activity_status":"active","employee_class":{"code":"1","name":"0 anställda"},"turnover_class":{"code":"2","name":"500 - 999 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"never_registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2025-09-01","to":"2026-08-31","framework":"K2","signed_on":"2026-09-29","documents":{"annual_report":"/v1/documents/99ffaf0c-4a5c-4da0-b102-276c4e80c573.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/40_2.zip"}},{"from":"2024-09-01","to":"2025-08-31","framework":"K2","signed_on":"2025-09-14","documents":{"annual_report":"/v1/documents/22d72a9a-191a-4284-808b-cb3c30188738.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/38_2.zip"}},{"from":"2023-09-01","to":"2024-08-31","framework":"K2","signed_on":"2024-09-20","documents":{"annual_report":"/v1/documents/0d7c1f1e-6e74-4a37-ba63-0ac95e4debfb.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/39_1.zip"}},{"from":"2022-09-01","to":"2023-08-31","framework":"K2","signed_on":"2023-09-29","documents":{"annual_report":"/v1/documents/38582600-659b-484f-bf40-a0e1e1d29148.xhtml"},"source":{"dataset":"arsredovisningar","file":"2023/39_2.zip"}},{"from":"2021-09-01","to":"2022-08-31","framework":"K2","signed_on":"2022-10-09","documents":{"annual_report":"/v1/documents/7e9d54a2-2a6a-4af9-a20e-3112fe38b805.xhtml"},"source":{"dataset":"arsredovisningar","file":"2022/43_2.zip"}},{"from":"2020-09-01","to":"2021-08-31","framework":"K2","signed_on":"2021-10-03","documents":{"annual_report":"/v1/documents/955335db-3530-4e16-9ac7-7875de5e4ae7.xhtml"},"source":{"dataset":"arsredovisningar","file":"2021/42_1.zip"}},{"from":"2019-09-01","to":"2020-08-31","framework":"K2","signed_on":"2020-10-03","documents":{"annual_report":"/v1/documents/976d1281-c407-43a9-a41b-dbf30c816bce.xhtml"},"source":{"dataset":"arsredovisningar","file":"2020/42_1.zip"}}],"latest_financials":{"from":"2025-09-01","to":"2026-08-31","scope":"company","currency":"SEK","net_sales":816181,"operating_profit":801075,"profit_after_financial_items":799903,"net_profit":634881,"total_assets":3019557,"current_assets":1476475,"equity":2948625,"share_capital":50000,"unrestricted_equity":2898625,"current_liabilities":70932,"tax_liabilities":6083,"cash":465492,"employees":0,"equity_ratio":0.98,"net_sales_growth":0.127,"source":{"annual_report":"2026-08-31","document":"/v1/documents/99ffaf0c-4a5c-4da0-b102-276c4e80c573.xhtml"},"anchors":{"cash":{"text":"465 492","prefix":"Summa kassa och bank","suffix":"449 949"},"current_assets":{"text":"1 476 475"},"current_liabilities":{"text":"70 932"},"employees":{"text":"0,0"},"equity":{"text":"2 948 625","prefix":"kapital"},"equity_ratio":{"text":"98","prefix":"Soliditet (%)"},"net_profit":{"text":"634 881","suffix":"571"},"net_sales":{"text":"816 181"},"operating_profit":{"text":"801 075"},"profit_after_financial_items":{"text":"799 903"},"share_capital":{"text":"50 000","prefix":"utgång"},"tax_liabilities":{"text":"6 083"},"total_assets":{"text":"3 019 557","prefix":"tillgångar"},"unrestricted_equity":{"text":"2 898 625","suffix":"Disponeras"}}},"officers":{"annual_report":"2026-08-31","signed_on":"2026-09-29","signatories":[{"name":"R*****","role":"Ordförande"},{"name":"S*****","role":"Styrelseledamot"},{"name":"S*****","role":"Styrelseledamot"},{"name":"A*****","role":"Styrelseledamot"}]}}